165
Views
2
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix

, , , &

References

  • Altaf FJ, Mokhtar GA, Altaf FM. 2013. Cervical Cancer Prevalence at King Abdulaziz University Hospital. Journal of American Science 9: 375–379.
  • Eze JN, Emeka-Irem EN, Edegbe FO. 2013. A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in Southeast Nigeria. Clinical Medicine Insights: Oncology 7:CMO.S12017–158.
  • Ferdous J, Begum SA, Ferdous NE, Nahar Q, Khatun SF, Khatun S. 2013. Presentation of invasive cervical cancer in Bangladesh. Bangabandhu Sheikh Mujib Medical University Journal 6: 29–32.
  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127: 2893–2917.
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. 2015. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136: E359–386.
  • Kava S, Rajaram S, Arora V, Goel N, Aggarwal S, Mehta S. 2015. Conventional cytology, visual tests and evaluation of P16(INK4A) as a biomarker in cervical intraepithelial neoplasia. Indian Journal of Cancer 52: 270–275.
  • Kim S, Cho H, Kang S, Kim H, Park S. 2011. Is the expression of p16INK4A and galectin-3 correlated with disease progression of cervical neoplasia? Korean Journal of Obstetrics 54: 192.
  • Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. 2001. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. International Journal of Cancer 92: 276–284.
  • Lee JW, Song SY, Choi JJ, Choi CH, Kim TJ, Kim J, et al. 2006. Decreased galectin-3 expression during the progression of cervical neoplasia. Journal of Cancer Research and Clinical Oncology 132: 241–247.
  • Li M, Feng YM, Fang SQ. 2017. Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer. Brazilian Journal of Medical and Biological Research 50: 5356.
  • Stiasny A, Freier CP, Kuhn C, Schulze S, Mayr D, Alexiou C, et al. 2017. The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer. Oncology Letters 14: 4467–4476.
  • Volgareva G, Zavalishina L, Andreeva Y, Frank G, Krutikova E, Golovina D, et al. 2004. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer 4: 58.
  • Wang JL, Zheng BY, Li XD, Nokelainen K, Angström T, Lindström MS, et al. 2005. p16INK4A and p14ARF expression pattern by immunohistochemistry in human papillomavirus-related cervical neoplasia. Modern Pathology 18:629–637.
  • Wu MZ, Wang S, Zheng M, Tian LX, Wu X, Guo KJ, et al. 2019. The diagnostic utility of p16 immunostaining in differentiating cancer and HSIL from LSIL and benign in cervical cells. Cell Transplantation 28:195–200.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.